Seaport Therapeutics, Inc. Ttl Fee Amt
Seaport Therapeutics, Inc. (SPTX) had Ttl Fee Amt of $22.76 thousand as of 2026-05-01, per its S-8 filed 2026-05-04.
Financial Statements › Notes
ffd:TtlFeeAmt · last filed 2026-05-04
- 2026-05-01: Ttl Fee Amt $22.76K.
- 2026-04-30: Ttl Fee Amt $6.75K.
- 2026-04-23: Ttl Fee Amt $33.73K.
- 2026-04-07: Ttl Fee Amt $13.81K.
| Period end | Ttl Fee Amt |
|---|---|
| 2026-05-01 | $22.76K S-8 · filed 2026-05-04 |
| 2026-04-30 | $6.75K S-1MEF · filed 2026-04-30 |
| 2026-04-23 | $33.73K S-1/A · filed 2026-04-27 |
| 2026-04-07 | $13.81K S-1 · filed 2026-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |